Manager, Digital Innovation at Bristol-Myers Squibb

Warsaw, Woj. Mazowieckie, Poland

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

Master’s degree in Business, Marketing, Life Sciences, Information Technology, or related field; advanced degree preferred
Proven experience (5+ years) in digital innovation, customer engagement solutions, or commercial excellence within the pharmaceutical, healthcare, or technology sectors
Good verbal and written communication skills (both in English and local language)
Strong track record in identifying, developing, and implementing digital tools and AI-driven solutions that enhance customer engagement and personalization

Responsibilities

Building strong partnerships with commercial, marketing, and sales leaders across Europe to discover high-impact opportunities where digital technology can elevate customer engagement and personalize communications
Scouting, evaluating, and rolling out best-in-class digital engagement tools and AI-powered platforms that optimize communication effectiveness and tailor messaging to individual stakeholder needs—deepening BMS’s connection with our customers and driving stronger outcomes
Designing and implementing solutions that enable data-driven, personalized content delivery, maximizing relevance and resonance in every interaction to fuel engagement and support commercial objectives
Facilitating collaboration across internal teams and external digital innovators to co-create and pilot new personalization and engagement solutions, ensuring a constant stream of fresh ideas
Crafting persuasive business cases that inspire investment in advanced digital engagement initiatives and mobilize cross-functional support, translating digital strategy into measurable commercial growth
Orchestrating seamless delivery from concept to launch by aligning diverse teams—Marketing, Sales, Medical, BI&A, Legal, Quality, Regulatory, and Procurement—towards ambitious customer engagement and personalization goals
Maximizing deployment by setting robust metrics and rigorously tracking performance, ensuring every solution delivers measurable impact on customer engagement, personalization, and business momentum
Inspiring a culture of innovation and agility, empowering teams to challenge conventions, embrace digital technologies, and drive sustained transformation in personalized customer engagement across BMS

Skills

Digital Innovation

Customer Engagement

Personalized Communication

Digital Tools

Commercial Acumen

Partnership Building

Marketing Strategy

Sales Enablement

Digital Solutions

Innovation Scouting

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free